About
We work at the edge
of what medicine and
AI can do together.
Our Story
From the operating theatre to the forefront of AI.
Trained in neurosurgery, worked with leading hospitals across the US, UK and Scandinavia, then moved to the forefront of AI.
xyva brings that rare intersection of clinical depth and AI expertise to the teams building what's next in healthcare.
Clinical experience across US, European and Scandinavian health systems.
Selected Publications
Journal of Neuro-Oncology · 2025
Circulating levels of glutamate predict brain disease in patients with advanced lung and breast cancer: a prospective study
World Neurosurgery · 2025
Radiotherapy for WHO grade 1 and 2 Intracranial Meningiomas — A Retrospective Analysis of Efficacy
Neuro-Oncology · 2022
The impact of neutrophils-to-lymphocytes ratio on survival in patients affected by brain metastases and treated with Gamma Knife Radiosurgery
Neuro-Oncology · 2022
Glutamate excitotoxicity in brain metastases from lung, breast, and melanoma treated with stereotactic radiosurgery
How We Work
Two principles. Every engagement.
Patient outcomes first.
Every recommendation we make traces back to one question: does this actually help patients? Not in theory. In the ward, the clinic, the real world.
Grounded in both worlds.
The gap between clinical reality and AI development is wide. We've worked on both sides of it. That's not a credential — it's the whole point.